Literature DB >> 18598772

Low dopamine striatal D2 receptors are associated with prefrontal metabolism in obese subjects: possible contributing factors.

Nora D Volkow1, Gene-Jack Wang, Frank Telang, Joanna S Fowler, Panayotis K Thanos, Jean Logan, David Alexoff, Yu-Shin Ding, Christopher Wong, Yeming Ma, Kith Pradhan.   

Abstract

Dopamine's role in inhibitory control is well recognized and its disruption may contribute to behavioral disorders of discontrol such as obesity. However, the mechanism by which impaired dopamine neurotransmission interferes with inhibitory control is poorly understood. We had previously documented a reduction in dopamine D2 receptors in morbidly obese subjects. To assess if the reductions in dopamine D2 receptors were associated with activity in prefrontal brain regions implicated in inhibitory control we assessed the relationship between dopamine D2 receptor availability in striatum with brain glucose metabolism (marker of brain function) in ten morbidly obese subjects (BMI>40 kg/m(2)) and compared it to that in twelve non-obese controls. PET was used with [(11)C]raclopride to assess D2 receptors and with [(18)F]FDG to assess regional brain glucose metabolism. In obese subjects striatal D2 receptor availability was lower than controls and was positively correlated with metabolism in dorsolateral prefrontal, medial orbitofrontal, anterior cingulate gyrus and somatosensory cortices. In controls correlations with prefrontal metabolism were not significant but comparisons with those in obese subjects were not significant, which does not permit to ascribe the associations as unique to obesity. The associations between striatal D2 receptors and prefrontal metabolism in obese subjects suggest that decreases in striatal D2 receptors could contribute to overeating via their modulation of striatal prefrontal pathways, which participate in inhibitory control and salience attribution. The association between striatal D2 receptors and metabolism in somatosensory cortices (regions that process palatability) could underlie one of the mechanisms through which dopamine regulates the reinforcing properties of food.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18598772      PMCID: PMC2659013          DOI: 10.1016/j.neuroimage.2008.06.002

Source DB:  PubMed          Journal:  Neuroimage        ISSN: 1053-8119            Impact factor:   6.556


  77 in total

1.  Extrastriatal dopamine D2 receptor density and affinity in the human brain measured by 3D PET.

Authors:  Tetsuya Suhara; Yasuhiko Sudo; Takashi Okauchi; Jun Maeda; Koichi Kawabe; Kazutoshi Suzuki; Yoshiro Okubo; Yoshifumi Nakashima; Hiroshi Ito; Shuji Tanada; Christer Halldin; Lars Farde
Journal:  Int J Neuropsychopharmacol       Date:  1999-06       Impact factor: 5.176

2.  Conditioning and extinction of a food-rewarded response after selective ablations of frontal cortex in rhesus monkeys.

Authors:  C M BUTTER; M MISHKIN; H E ROSVOLD
Journal:  Exp Neurol       Date:  1963-01       Impact factor: 5.330

3.  How cognition modulates affective responses to taste and flavor: top-down influences on the orbitofrontal and pregenual cingulate cortices.

Authors:  Fabian Grabenhorst; Edmund T Rolls; Amy Bilderbeck
Journal:  Cereb Cortex       Date:  2007-12-01       Impact factor: 5.357

4.  Polymorphisms in the dopamine D2 receptor gene and their relationships to striatal dopamine receptor density of healthy volunteers.

Authors:  E G Jönsson; M M Nöthen; F Grünhage; L Farde; Y Nakashima; P Propping; G C Sedvall
Journal:  Mol Psychiatry       Date:  1999-05       Impact factor: 15.992

5.  Topographic projections on the globus pallidus and the substantia nigra of selectively placed lesions in the precommissural caudate nucleus and putamen in the monkey.

Authors:  T N Johnson; H E Rosvold
Journal:  Exp Neurol       Date:  1971-12       Impact factor: 5.330

6.  Orbitofrontal cortex and basolateral amygdala encode expected outcomes during learning.

Authors:  G Schoenbaum; A A Chiba; M Gallagher
Journal:  Nat Neurosci       Date:  1998-06       Impact factor: 24.884

7.  Graphical analysis of reversible radioligand binding from time-activity measurements applied to [N-11C-methyl]-(-)-cocaine PET studies in human subjects.

Authors:  J Logan; J S Fowler; N D Volkow; A P Wolf; S L Dewey; D J Schlyer; R R MacGregor; R Hitzemann; B Bendriem; S J Gatley
Journal:  J Cereb Blood Flow Metab       Date:  1990-09       Impact factor: 6.200

8.  Decision-making in obesity: a study using the Gambling Task.

Authors:  R Pignatti; L Bertella; G Albani; A Mauro; E Molinari; C Semenza
Journal:  Eat Weight Disord       Date:  2006-09       Impact factor: 4.652

9.  Cognitive function in normal-weight, overweight, and obese older adults: an analysis of the Advanced Cognitive Training for Independent and Vital Elderly cohort.

Authors:  Hsu-Ko Kuo; Richard N Jones; William P Milberg; Sharon Tennstedt; Laura Talbot; John N Morris; Lewis A Lipsitz
Journal:  J Am Geriatr Soc       Date:  2006-01       Impact factor: 5.562

10.  Prevalence of attention deficit/hyperactivity disorder among adults in obesity treatment.

Authors:  Jules R Altfas
Journal:  BMC Psychiatry       Date:  2002-09-13       Impact factor: 3.630

View more
  235 in total

1.  Relation between changes in neural responsivity and reductions in desire to eat high-calorie foods following gastric bypass surgery.

Authors:  C N Ochner; E Stice; E Hutchins; L Afifi; A Geliebter; J Hirsch; J Teixeira
Journal:  Neuroscience       Date:  2012-02-24       Impact factor: 3.590

Review 2.  Common cellular and molecular mechanisms in obesity and drug addiction.

Authors:  Paul J Kenny
Journal:  Nat Rev Neurosci       Date:  2011-10-20       Impact factor: 34.870

3.  Frequent ice cream consumption is associated with reduced striatal response to receipt of an ice cream-based milkshake.

Authors:  Kyle S Burger; Eric Stice
Journal:  Am J Clin Nutr       Date:  2012-02-15       Impact factor: 7.045

4.  New operant model of reinstatement of food-seeking behavior in mice.

Authors:  Elena Martín-García; Aurelijus Burokas; Elzbieta Kostrzewa; Agnieszka Gieryk; Michal Korostynski; Barbara Ziolkowska; Barbara Przewlocka; Ryszard Przewlocki; Rafael Maldonado
Journal:  Psychopharmacology (Berl)       Date:  2010-12-14       Impact factor: 4.530

Review 5.  Dopamine-related frontostriatal abnormalities in obesity and binge-eating disorder: emerging evidence for developmental psychopathology.

Authors:  Michael Michaelides; Panayotis K Thanos; Nora D Volkow; Gene-Jack Wang
Journal:  Int Rev Psychiatry       Date:  2012-06

6.  Loudness dependence of auditory evoked potentials (LDAEP) correlates with the availability of dopamine transporters and serotonin transporters in healthy volunteers-a two isotopes SPECT study.

Authors:  I Hui Lee; Yen Kuang Yang; Po See Chen; Hui Chun Huang; Tzung Lieh Yeh; Ru-Band Lu; Nan-Tsing Chiu; Wei Jen Yao; Shih-Hsien Lin
Journal:  Psychopharmacology (Berl)       Date:  2010-11-12       Impact factor: 4.530

Review 7.  Molecular imaging and neural networks in impulse control disorders in Parkinson's disease.

Authors:  I Aracil-Bolaños; A P Strafella
Journal:  Parkinsonism Relat Disord       Date:  2015-08-12       Impact factor: 4.891

8.  Striatal dopamine type 2 receptor availability in anorexia nervosa.

Authors:  Allegra Broft; Mark Slifstein; Joseph Osborne; Paresh Kothari; Simon Morim; Rebecca Shingleton; Lindsay Kenney; Shankar Vallabhajosula; Evelyn Attia; Diana Martinez; B Timothy Walsh
Journal:  Psychiatry Res       Date:  2015-07-26       Impact factor: 3.222

9.  The TaqIA RFLP is associated with attenuated intervention-induced body weight loss and increased carbohydrate intake in post-menopausal obese women.

Authors:  Jameason D Cameron; Marie-Ève Riou; Frédérique Tesson; Gary S Goldfield; Rémi Rabasa-Lhoret; Martin Brochu; Éric Doucet
Journal:  Appetite       Date:  2012-09-29       Impact factor: 3.868

Review 10.  Obesity and Brain Positron Emission Tomography.

Authors:  Kyoungjune Pak; Seong-Jang Kim; In Joo Kim
Journal:  Nucl Med Mol Imaging       Date:  2017-05-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.